Evaluation of the Fr1da screening: From an epidemiological perspective.
Evaluation of the Fr1da-screening from an epidemiological perspective.
Diabetologie 14, 221-223 (2018)
Background: In the Fr1da study (“Typ 1 Diabetes: Früh erkennen – Früh gut behandeln”), children between 2 and 5 years of age are screened for presymptomatic type 1 diabetes in Bavaria, Germany. Objectives: Here, we show preliminary results on the success and acceptance of the Fr1da screening. Materials and methods: Participation rates, analytic quality, as well as the well-being and the ketoacidosis rates in families with presymptomatic type 1 diabetes were considered as main criteria. Results: Between 2015 and 2017, 72,459 children participated in the Fr1da screening. None of the 223 children (0.3%) diagnosed with presymptomatic type 1 diabetes have had a ketoacidosis event. In 95% of the affected families, no or only mild depressive symptoms were reported after diagnosis. Conclusions: The acceptance of the Fr1da screening among the participating physicians and families is high. It is particularly encouraging that no ketoacidosis has been reported yet in any of the children with early type 1 diabetes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Review
Thesis type
Editors
Keywords
Autoantibodies ; Child ; Diabetes Mellitus, Type 1 ; Early Diagnosis ; Ketoacidosis; Cell-line Thp-1; In-vitro; Hacat Keratinocytes; Alkaloid Berberine; Dendritic Cells; Injury; Skin; Sensitization; Expression; Toxicity
Keywords plus
Language
english
Publication Year
2018
Prepublished in Year
HGF-reported in Year
2018
ISSN (print) / ISBN
2731-7447
e-ISSN
2731-7455
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 14,
Issue: 4,
Pages: 221-223
Article Number: ,
Supplement: ,
Series
Publisher
Springer
Publishing Place
Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30201 - Metabolic Health
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502100-001
G-501900-217
Grants
Copyright
Erfassungsdatum
2018-07-09